1. Home
  2. MAIA
  3. MAIA News

Latest MAIA Biotechnology Inc. (MAIA) News on June 6, 2025

MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer
MAIA

Business Wire

14 hours ago

MAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung Cancer

MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial
MAIA

Insider Monkey

9 days ago

MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial

CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000
MAIA

Business Wire

9 days ago

CORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000

MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
MAIA

Business Wire

21 days ago

MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

MAIA Biotechnology Announces Director Participation in Recent Private Placement
MAIA

Business Wire

22 days ago

MAIA Biotechnology Announces Director Participation in Recent Private Placement

Best Momentum Stocks to Buy for May 6th
MAIA

Zacks

a month ago

Best Momentum Stocks to Buy for May 6th

New Strong Buy Stocks for May 6th
MAIA

Zacks

a month ago

New Strong Buy Stocks for May 6th

CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement
MAIA

Business Wire

a month ago

CORRECTION: MAIA Biotechnology Announces $1.08 Million Private Placement

MAIA Biotechnology Announces $1.08 Million Private Placement
MAIA

Business Wire

a month ago

MAIA Biotechnology Announces $1.08 Million Private Placement

MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders
MAIA

Business Wire

2 months ago

MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders

Is MAIA Biotechnology, Inc. (MAIA)he Cheapest Stock Insiders Are Buying In March?
MAIA

Insider Monkey

2 months ago

Is MAIA Biotechnology, Inc. (MAIA)he Cheapest Stock Insiders Are Buying In March?

MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know
MAIA

Zacks

2 months ago

MAIA Biotechnology, Inc. (MAIA) Upgraded to Buy: Here's What You Should Know

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025
MAIA

Business Wire

2 months ago

MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025

MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug
MAIA

Business Wire

3 months ago

MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug

MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO
MAIA

Business Wire

3 months ago

MAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIO

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients
MAIA

Business Wire

3 months ago

MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer Patients

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer
MAIA

Business Wire

3 months ago

MAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung Cancer

MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million
MAIA

Business Wire

3 months ago

MAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 Million

MAIA Biotechnology Announces Private Placement of $2,715,000
MAIA

Business Wire

4 months ago

MAIA Biotechnology Announces Private Placement of $2,715,000

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer
MAIA

Business Wire

4 months ago

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer

MAIA Biotechnology to Present at Biotech Showcase 2025
MAIA

Business Wire

5 months ago

MAIA Biotechnology to Present at Biotech Showcase 2025

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications
MAIA

Business Wire

5 months ago

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications

MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings
MAIA

Business Wire

6 months ago

MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings

MAIA

MT Newswires

6 months ago

MAIA Biotechnology's THIO Gets US FDA Rare Pediatric Disease Designation to Treat Pediatric High-Grade Gliomas

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
MAIA

Business Wire

6 months ago

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

MAIA Biotechnology Announces Private Placement of Approximately $950,000
MAIA

Business Wire

6 months ago

MAIA Biotechnology Announces Private Placement of Approximately $950,000

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer
MAIA

Business Wire

6 months ago

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement
MAIA

Business Wire

7 months ago

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
MAIA

Business Wire

7 months ago

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

MAIA Biotechnology Announces $2.44 Million Private Placement
MAIA

Business Wire

7 months ago

MAIA Biotechnology Announces $2.44 Million Private Placement

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics
MAIA

Business Wire

8 months ago

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer
MAIA

Business Wire

9 months ago

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference
MAIA

Business Wire

9 months ago

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference

MAIA

MT Newswires

10 months ago

Top Premarket Gainers

MAIA

MT Newswires

10 months ago

MAIA Biotechnology Says Cancer Treatment Agent Was Well Tolerated in Mid-Stage Trial

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent
MAIA

Business Wire

10 months ago

MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent

MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
MAIA

Business Wire

a year ago

MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy

MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent

MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
MAIA

Business Wire

a year ago

MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer

MAIA Biotechnology to Present at the BIO International Convention 2024
MAIA

Business Wire

a year ago

MAIA Biotechnology to Present at the BIO International Convention 2024

MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
MAIA

Business Wire

a year ago

MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement

MAIA Biotechnology Announces $1.00 Million Private Placement
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces $1.00 Million Private Placement

MAIA Biotechnology to Present at Two Investor Conferences in April 2024
MAIA

Business Wire

a year ago

MAIA Biotechnology to Present at Two Investor Conferences in April 2024

MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement

MAIA Biotechnology Announces $1.33 Million Private Placement
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces $1.33 Million Private Placement

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement

MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board
MAIA

Business Wire

a year ago

MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board

Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA)
MAIA

GuruFocus.com

a year ago

Director Ngar Louie Acquires 170,940 Shares of MAIA Biotechnology Inc (MAIA)

MAIA Biotechnology to Participate in the 36th Annual ROTH Conference
MAIA

Business Wire

a year ago

MAIA Biotechnology to Participate in the 36th Annual ROTH Conference

MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting
MAIA

Business Wire

a year ago

MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting

MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients

MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders
MAIA

Business Wire

a year ago

MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders

MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor
MAIA

GlobeNewswire

a year ago

MAIA Biotechnology Appoints Leading Immuno-Oncology Scientist Dr. Remus Vezan as Scientific Advisor

MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
MAIA

GlobeNewswire

a year ago

MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer

MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer

Middlefield Banc Corp. (MBCN) Reports Record Annual Net Income for 2023
MAIA

GuruFocus.com

a year ago

Middlefield Banc Corp. (MBCN) Reports Record Annual Net Income for 2023

MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Publication of International PCT Patent Application Covering Anticancer Telomere-Targeting Compounds

Lightbridge Announces Upcoming Industry Event and Media Interview
MAIA

GlobeNewswire

a year ago

Lightbridge Announces Upcoming Industry Event and Media Interview

We're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Rate
MAIA

Simply Wall St.

a year ago

We're Not Very Worried About Trevi Therapeutics' (NASDAQ:TRVI) Cash Burn Rate

MAIA Soars 20% on Interim Results From Lung Cancer Study
MAIA

Zacks

a year ago

MAIA Soars 20% on Interim Results From Lung Cancer Study

Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for Investors
MAIA

Zacks

a year ago

Aquestive Therapeutics (AQST) Declines More Than Market: Some Information for Investors

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024
MAIA

Business Wire

a year ago

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

MAIA

Reuters

a year ago

GRAPHIC-As price parity beckons, substitution from palladium to platinum to wane

Here's Why We Think First US Bancshares (NASDAQ:FUSB) Is Well Worth Watching
MAIA

Simply Wall St.

a year ago

Here's Why We Think First US Bancshares (NASDAQ:FUSB) Is Well Worth Watching

Workhorse Group Receives Second Fleet Order for W56 Step Van
MAIA

GlobeNewswire

a year ago

Workhorse Group Receives Second Fleet Order for W56 Step Van

At the 2024 Golden Globes, Diamonds Were Forever
MAIA

WWD

a year ago

At the 2024 Golden Globes, Diamonds Were Forever

Investors in InterGroup (NASDAQ:INTG) from a year ago are still down 51%, even after 16% gain this past week
MAIA

Simply Wall St.

a year ago

Investors in InterGroup (NASDAQ:INTG) from a year ago are still down 51%, even after 16% gain this past week

Alico, Inc. to Attend the 2024 ICR Conference in Orlando, Florida
MAIA

GlobeNewswire

a year ago

Alico, Inc. to Attend the 2024 ICR Conference in Orlando, Florida

MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024
MAIA

Business Wire

a year ago

MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024

Apollomics to Present at the 2024 Biotech Showcase
MAIA

GlobeNewswire

a year ago

Apollomics to Present at the 2024 Biotech Showcase

MAIA

GlobeNewswire

a year ago

Digihost’s Hashrate Doubles to 2EH/s as of January 1st 2024

When Should You Buy Intellicheck, Inc. (NASDAQ:IDN)?
MAIA

Simply Wall St.

a year ago

When Should You Buy Intellicheck, Inc. (NASDAQ:IDN)?

TSX Venture Exchange Stock Maintenance Bulletins
MAIA

CNW Group

a year ago

TSX Venture Exchange Stock Maintenance Bulletins

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation
MAIA

GlobeNewswire

a year ago

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

Canadian Investment Regulatory Organization Trade Resumption - DGHI
MAIA

CNW Group

a year ago

Canadian Investment Regulatory Organization Trade Resumption - DGHI

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease
MAIA

GlobeNewswire

a year ago

NKGen Biotech Announces Clearance of Clinical Trial Application by Health Canada for SNK01 NK Cell Therapy to Treat Alzheimer’s Disease

Forum Energy Technologies Receives Approval to Proceed with Variperm Acquisition from Canadian Competition Bureau
MAIA

Business Wire

a year ago

Forum Energy Technologies Receives Approval to Proceed with Variperm Acquisition from Canadian Competition Bureau

MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
MAIA

Business Wire

a year ago

MAIA Biotechnology Announces Dose Selection in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer

Insider Spends US$100k Buying More Shares In Cytosorbents
MAIA

Simply Wall St.

a year ago

Insider Spends US$100k Buying More Shares In Cytosorbents

Are Investors Undervaluing Brilliant Earth Group, Inc. (NASDAQ:BRLT) By 44%?
MAIA

Simply Wall St.

a year ago

Are Investors Undervaluing Brilliant Earth Group, Inc. (NASDAQ:BRLT) By 44%?

We Think ReWalk Robotics (NASDAQ:RWLK) Needs To Drive Business Growth Carefully
MAIA

Simply Wall St.

2 years ago

We Think ReWalk Robotics (NASDAQ:RWLK) Needs To Drive Business Growth Carefully

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology
MAIA

PR Newswire

2 years ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now
MAIA

Zacks

2 years ago

Bears are Losing Control Over MAIA Biotechnology, Inc. (MAIA), Here's Why It's a 'Buy' Now

LifeVantage® Study Reveals Synergistic Effects of Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen
MAIA

GlobeNewswire

2 years ago

LifeVantage® Study Reveals Synergistic Effects of Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen

Hudson RPO APAC Receives the Prestigious 2023 SEEK SARA RPO of the Year Award in Australia
MAIA

GlobeNewswire

2 years ago

Hudson RPO APAC Receives the Prestigious 2023 SEEK SARA RPO of the Year Award in Australia

authID INC. Announces Closing of $9.4 Million Registered Direct Offering
MAIA

GlobeNewswire

2 years ago

authID INC. Announces Closing of $9.4 Million Registered Direct Offering

13 Stocks Insiders are Buying Now
MAIA

Insider Monkey

2 years ago

13 Stocks Insiders are Buying Now

What Makes Ashford Hospitality Trust (AHT) a New Buy Stock
MAIA

Zacks

2 years ago

What Makes Ashford Hospitality Trust (AHT) a New Buy Stock

Clean Energy Technologies, Inc. Leads Discussions on Sustainable Energy at APEC 2023
MAIA

GlobeNewswire

2 years ago

Clean Energy Technologies, Inc. Leads Discussions on Sustainable Energy at APEC 2023

MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering
MAIA

Business Wire

2 years ago

MAIA Biotechnology Announces Closing of $4 Million Registered Direct Offering

MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer
MAIA

ACCESSWIRE

2 years ago

MAIA Biotechnology (NYSE: MAIA) Has Received FDA Orphan Drug Designation For THIO As A Treatment For Most Aggressive Brain Cancer

Sonder Holdings Inc. Announces Third Quarter 2023 Financial Results
MAIA

GlobeNewswire

2 years ago

Sonder Holdings Inc. Announces Third Quarter 2023 Financial Results

Sidoti Events, LLC’s Virtual November Micro-Cap Conference
MAIA

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Thinking about buying stock in Tivic Health Systems, Tigo Energy, TAT Technologies, Plus Therapeutics, or Acumen Pharmaceuticals?
MAIA

PR Newswire

2 years ago

Thinking about buying stock in Tivic Health Systems, Tigo Energy, TAT Technologies, Plus Therapeutics, or Acumen Pharmaceuticals?

Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
MAIA

GlobeNewswire

2 years ago

Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story
MAIA

Simply Wall St.

2 years ago

Wag! Group Co.'s (NASDAQ:PET) Shares Not Telling The Full Story

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q3 2023 Earnings Call Transcript
MAIA

Insider Monkey

2 years ago

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Q3 2023 Earnings Call Transcript

Share on Social Networks: